IntroductionCancer continues to be among the most lethal diseases globally, with millions of new cases annually. Traditional anticancer agents such as chemotherapy and radiation therapy tend to have...
CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary therapeutic strategy in hematologic malignancy treatment, recording high remission rates in therapy-refractory cas...
IntroductionCancer is still one of the most difficult diseases to cure, and conventional treatments such as chemotherapy, radiation, and surgery have yielded limited success and severe side effects....
CAR immune Cell therapyChimeric Antigen Receptor (CAR) immune cell therapy has transformed the treatment of cancer, especially for hematological cancers. Its effectiveness notwithstanding, it still ...
CAR T Cell therapyChimeric Antigen Receptor (CAR) T cell therapy has transformed cancer treatment by genetically modifying a patient's own T cells to target and destroy cancer cells. Although this a...
CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...
June 2024: The Food and Drug Administration has given accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.), a bispecific CD20-directed CD3 T-cell engager, for adult patients with recurr...
Tips to reduce the risk of cancer Although the exact cause of cancer is still unknown and a lot of research has been conducted to unearth this area, the lifestyle choices one makes do determine the c...
The latest research and analysis of the landmark Framingham Heart Study by researchers at Vanderbilt University Medical Center suggest that the risk of lung cancer is drastically increased within 5 ye...